AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.36 BRL | +0.43% |
|
+5.49% | +20.84% |
| 06-21 | US FDA approves Roche's drug for a chronic blood disorder | RE |
| 06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 796B | ||||||
| 628B | ||||||
| 358B | - | - | - | - | ||
| 331B | ||||||
| 301B |
